Silk Road Medical's (SILK) New Launch to Aid Its TCAR Portfolio
https://www.zacks.com/stock/news/2252006/silk-road-medical-s-silk-new-launch-to-aid-its-tcar-portfolio?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2252006
Apr 08, 2024 - Silk Road Medical (SILK) announces its latest launch of ENROUTE Transcarotid Neuroprotection System PLUS, which is likely to aid in TCAR procedures.
0
Abbott (ABT) Faces Low Testing Demand, Currency Headwinds
https://www.zacks.com/stock/news/2251992/abbott-abt-faces-low-testing-demand-currency-headwinds?cid=CS-ZC-FT-analyst_blog|zer_report_update-2251992
Apr 08, 2024 - Abbott's (ABT) core laboratory diagnostics business is gaining strength on the continued success of the Alinity suite of diagnostics instruments, along with a broad test menu offering.
0
IM Cannabis (IMCC) Expands Business in Germany With New Alliance
https://www.zacks.com/stock/news/2251935/im-cannabis-imcc-expands-business-in-germany-with-new-alliance?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251935
Apr 08, 2024 - The partnership's core objective is to grant IM Cannabis' (IMCC) subsidiary, Adjupharm GmbH, exclusive rights to introduce Avant's BLK MKT cannabis brand in Germany's medical cannabis market.
0
Here's Why You Should Retain Penumbra (PEN) Stock for Now
https://www.zacks.com/stock/news/2252020/here-s-why-you-should-retain-penumbra-pen-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2252020
Apr 08, 2024 - Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
0
Labcorp (LH) Extends MRD Clinical Research With New Launch
https://www.zacks.com/stock/news/2252021/labcorp-lh-extends-mrd-clinical-research-with-new-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2252021
Apr 08, 2024 - Labcorp (LH) Plasma Detect MRD solution advances its leadership in precision oncology across the solid tumor oncology care continuum.
0
AngioDynamics' (ANGO) AlphaVac Gets FDA Nod for PE Treatment
https://www.zacks.com/stock/news/2251310/angiodynamics-ango-alphavac-gets-fda-nod-for-pe-treatment?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251310
Apr 05, 2024 - AngioDynamics (ANGO) announces the FDA's approval of its AlphaVac F1885 System, which is likely to expand the range of therapy alternatives available to pulmonary embolism patients.
0
Abbott (ABT) Receives FDA's Approval for the TriClip TEER System
https://www.zacks.com/stock/news/2251212/abbott-abt-receives-fda-s-approval-for-the-triclip-teer-system?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251212
Apr 05, 2024 - Abbott (ABT) receives FDA nod for TriClip, a first-of-its-kind device to repair a leaky tricuspid heart valve.
0
Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval
https://www.zacks.com/stock/news/2251191/haemonetics-hae-new-teg-6s-cartridge-gets-fda-approval?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251191
Apr 05, 2024 - Haemonetics' (HAE) TEG testing gives vital information that can assist doctors with better control of their patients' hemostasis.
0
QIAGEN (QGEN) Boosts Cancer Research Suite With New Launches
https://www.zacks.com/stock/news/2250721/qiagen-qgen-boosts-cancer-research-suite-with-new-launches?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2250721
Apr 04, 2024 - QIAGEN's (QGEN) new products, coupled with the IVD version of QIAGEN's digital PCR platform QIAcuity, are planned to be released in mid-2024.
0
Why Cardinal (CAH) is Poised to Beat Earnings Estimates Again
https://www.zacks.com/stock/news/2250666/why-cardinal-cah-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2250666
Apr 04, 2024 - Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
0